AnTran Business Corporation – Trademark Portfolio

Entity Type: 03

AnTran Business Corporation holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 43 (Hotels & Restaurants) — 1 filings in this category. The portfolio also extends into Class 30 (Staple Foods) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include CRUSTACEAN. The owner is based in San Francisco, CA.

4101 Judah Street

San Francisco, CA 94122

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

AnTran Business Corporation's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

43
Hotels & Restaurants (1 filing)

Services for providing food and drink; temporary accommodation

30
Staple Foods (1 filing)

Coffee, tea, cocoa and artificial coffee; rice; tapioca and sago; flour and preparations

Frequently Asked Questions

How many trademarks does AnTran Business Corporation have?

AnTran Business Corporation has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 cancelled.

What trademark classes does AnTran Business Corporation file in?

AnTran Business Corporation files trademarks across 2 Nice Classification classes. The most active classes are Class 43 (Hotels & Restaurants), Class 30 (Staple Foods). Class 43 covers services for providing food and drink; temporary accommodation.

What are AnTran Business Corporation's most well-known trademarks?

AnTran Business Corporation's registered trademark portfolio includes well-known marks such as CRUSTACEAN. These are among 1 currently registered trademark in the portfolio.

What is AnTran Business Corporation's trademark registration success rate?

AnTran Business Corporation has a 50% trademark registration rate, with 1 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.